Prevention against renal damage in rats with subtotal nephrectomy by sacubitril/valsartan (LCZ696), a dual-acting angiotensin receptor-neprilysin inhibitor-Reference-Cited by-同舟云学术

Prevention against renal damage in rats with subtotal nephrectomy by sacubitril/valsartan (LCZ696), a dual-acting angiotensin receptor-neprilysin inhibitor

Published:2017-07-19 Issue:4 Volume:5 Page:e00336
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Ushijima Kentaro¹,Ando Hitoshi²,Arakawa Yusuke³,Aizawa Kenichi¹,Suzuki Chisato⁴,Shimada Ken⁴,Tsuruoka Shu-ichi³,Fujimura Akio¹^ORCID

Affiliation:

1. Division of Clinical Pharmacology; Department of Pharmacology; Jichi Medical University; Shimotsuke Tochigi Japan

2. Department of Cellular and Molecular Function Analysis; Kanazawa University; Kanazawa Ishikawa Japan

3. Division of Nephrology; Department of Internal Medicine; Nippon Medical University; Bunkyo-ku Tokyo Japan

4. Department of Pharmaceutics & Drug Delivery Systems; Tokyo University of Sciences; Noda, Chiba Japan

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Reference25 articles.

1. Should we stop angiotensin converting enzyme inhibitors/angiotensin receptor blockers in advanced kidney disease?;Ahmed;Nephron,2016

2. Nitric oxide/endothelin balance after nephron reduction;Aiello;Kidney Int,1998

3. Endothelin antagonists in renal disease;Benigni;Kidney Int,2000

4. Renoprotection by nitric oxide donor and Lisinopril in the remnant kidney model;Benigni;Am J Kidney Dis,1999

5. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy;Benigni;Kidney Int,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative renoprotection: Sacubitril/valsartan versus ACEI or ARB -A systematic review and meta-analysis;Tropical Journal of Pharmaceutical Research;2024-03-12

2. Sacubitril/valsartan ameliorates tubulointerstitial fibrosis by restoring mitochondrial homeostasis in diabetic kidney disease;Diabetology & Metabolic Syndrome;2024-02-10

3. Sacubitril/valsartan ameliorates tubulointerstitial fibrosis by restoring mitochondrial homeostasis in diabetic kidney disease;2024-01-15

4. Protective effect of novel angiotensin receptor neprilysin inhibitor S086 on target organ injury in spontaneously hypertensive rats;Biomedicine & Pharmacotherapy;2024-01

5. Sacubitril/Valsartan in Dialysis Patients: Update on Current Perspectives;Cardiovascular Drugs and Therapy;2023-06-22